{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:16:18Z","timestamp":1790957778470,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study is to assess whether duration and size of the arterial duct were associated with severe respiratory morbidity and mortality in preterm infants. All echocardiography evaluations for patent ductus arteriosus (PDA) in a cohort of preterm infants, born at a gestational age less than 28\u00a0weeks, from birth up to 36\u00a0weeks of postconceptional age or final ductal closure were reviewed. Ductal size was measured at the pulmonary end. PDA was classified as small (E1: ductal diameter (DD)\u2009\u2264\u20091.5\u00a0mm), moderate (E2: 1.5\u00a0mm\u2009&lt;\u2009DD\u2009\u2264\u20092.5\u00a0mm), or large (E3) (DD\u2009&gt;\u20092.5\u00a0mm). The primary outcome was adverse outcome defined by the composite outcome of bronchopulmonary dysplasia (BPD) or death. Infants in whom the primary outcome occurred were classified as \u201chigh-risk\u201d whereas patients who did not satisfy this outcome were classified as \u201clow-risk\u201d. Intergroup comparison (high vs. low risk) was performed using univariate and multivariate analyses. A total of 135 infants, born between 2010 and 2020, were evaluated. The primary outcome was satisfied in 46 (34.1%) patients. The high-risk group was characterized by increased duration of exposure to PDA of any (E1\/E2\/E3) grade (44 vs. 25.5\u00a0days, <jats:italic>p<\/jats:italic>\u2009=\u2009.0004), moderate or large (E2\/E3) PDA (30.5 vs. 11.5\u00a0days, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.0001), moderate (E2) PDA (10.8 vs.6\u00a0days, <jats:italic>p<\/jats:italic>\u2009=\u20090.05), and large (E3) PDA (11.5 vs.0\u00a0days, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.0001) compared with low-risk group. Lower gestational age, prolonged duration of mechanical ventilation, higher rate of inotrope use, pharmacological therapy, and PDA ligation were also associated with development of BPD or death (high-risk group). After adjusting for confounders, the rate of inotrope use [OR 2.688, 95% CI (1.011\u20137.142), <jats:italic>p<\/jats:italic>\u2009=\u20090.047], duration of large (E3) PDA [OR 1.060, 95% CI (1.005\u20131.118), <jats:italic>p<\/jats:italic>\u2009=\u20090.03], and mechanical ventilation [OR 1.130, 95% CI (1.064\u20131.200), <jats:italic>p<\/jats:italic>\u2009=\u20090.0001] were independently associated with the composite of BPD or death. Among infants who developed BPD, 27 were classified as grade I and 18 as grade II BPD, respectively. Infants with grade II BPD had prolonged MV (20.0 vs. 9.0\u00a0days, <jats:italic>p<\/jats:italic>\u2009=\u20090.024), prolonged exposure to PDA of any grade (55.8 vs. 36.0\u00a0days, <jats:italic>p<\/jats:italic>\u2009=\u20090.03), and prolonged exposure to large (E3) PDA compared with infants with grade I BPD.<\/jats:p><jats:p><jats:italic>\u00a0 \u00a0Conclusion<\/jats:italic>: Prolonged exposure to a large PDA was associated with severe respiratory morbidity and mortality in preterm infants. The modulator role of early intervention, in the most pathologic shunts, on severe respiratory morbidity in preterm infants should be tested in well-designed clinical trials.<jats:table-wrap><jats:table><jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>What is Known:<\/jats:bold><jats:italic>\u2022 Current guidelines recommended against accelerating PDA closure of preterm infants within 2 weeks of life, with low certainty evidence indicating improved long-term outcomes.<\/jats:italic><jats:italic>\u2022 Recent studies suggest that conservative approach regarding PDA management has detrimental effects on the respiratory outcomes in a subgroup population.<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>What is New:<\/jats:bold><jats:italic>\u2022 Persistent patency of significant PDA is associated with increased risk of BPD\/death in extremely preterm infants.<\/jats:italic><jats:italic>\u2022 Targeted intervention of PDA is beneficial for the at-risk preterm infants with increased PDA hemodynamic significance.<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>","DOI":"10.1007\/s00431-022-04549-x","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T07:02:56Z","timestamp":1657868576000},"page":"3131-3140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China"],"prefix":"10.1007","volume":"181","author":[{"given":"Yingping","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimiao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-8872","authenticated-orcid":false,"given":"Patrick J.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"4549_CR1","doi-asserted-by":"publisher","unstructured":"Benitz WE (2016) Patent ductus arteriosus in preterm infants. Pediatrics 137:e 20153730. https:\/\/doi.org\/10.1542\/peds.2015-3730","DOI":"10.1542\/peds.2015-3730"},{"key":"4549_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/chd.12708","volume":"14","author":"S Bhombal","year":"2019","unstructured":"Bhombal S, Benitz WE (2019) PDA\u202f: to treat or not to treat. Congenit Heart Dis 14:46\u201351. https:\/\/doi.org\/10.1111\/chd.12708","journal-title":"Congenit Heart Dis"},{"key":"4549_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jpeds.2012.05.007","volume":"161","author":"L Mirea","year":"2012","unstructured":"Mirea L, Sankaran K, Seshia M et al (2012) Treatment of patent ductus arteriosus and neonatal mortality\/morbidities: adjustment for treatment selection bias. J Pediatr 161:689\u2013694.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2012.05.007","journal-title":"J Pediatr"},{"key":"4549_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/157339631202160506001621","volume":"12","author":"EJ Kort","year":"2016","unstructured":"Kort EJ (2016) Patent ductus arteriosus in the preterm infant\u202f: an update. Curr Pediatr Rev 12:98\u2013105. https:\/\/doi.org\/10.2174\/157339631202160506001621","journal-title":"Curr Pediatr Rev"},{"key":"4549_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003481.pub8","author":"A Ohlsson","year":"2018","unstructured":"Ohlsson A, Walia R, Shah SS (2018) Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003481.pub8","journal-title":"Cochrane Database Syst Rev"},{"key":"4549_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpeds.2018.09.012","volume":"205","author":"RI Clyman","year":"2019","unstructured":"Clyman RI, Liebowitz M, Kaempf J et al (2019) PDA-TOLERATE trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J Pediatr 205:41\u201348.e6. https:\/\/doi.org\/10.1016\/j.jpeds.2018.09.012","journal-title":"J Pediatr"},{"key":"4549_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/jp.2010.3","volume":"30","author":"WE Benitz","year":"2010","unstructured":"Benitz WE (2010) Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis. J Perinatol 30:241\u2013252. https:\/\/doi.org\/10.1038\/jp.2010.3","journal-title":"J Perinatol"},{"key":"4549_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1055\/s-0039-1697674","volume":"38","author":"V Aldecoa-Bilbao","year":"2021","unstructured":"Aldecoa-Bilbao V, Garc\u00eda-Catal\u00e1n MJ, Gaixa M et al (2021) Neurodevelopmental impairment at two years in premature infants with prolonged patency of ductus arteriosus after a conservative approach. Am J Perinatol 38:449\u2013455. https:\/\/doi.org\/10.1055\/s-0039-1697674","journal-title":"Am J Perinatol"},{"key":"4549_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.earlhumdev.2016.12.008","volume":"104","author":"JB Letshwiti","year":"2017","unstructured":"Letshwiti JB, Semberova J, Pichova K et al (2017) A conservative treatment of patent ductus arteriosus in very low birth weight infants. Early Hum Dev 104:45\u201349. https:\/\/doi.org\/10.1016\/j.earlhumdev.2016.12.008","journal-title":"Early Hum Dev"},{"key":"4549_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jpeds.2015.09.028","volume":"167","author":"A El-Khuffash","year":"2015","unstructured":"El-Khuffash A, James AT, Corcoran JD avi et al (2015) A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr 167:1354\u20131361.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2015.09.028","journal-title":"J Pediatr"},{"key":"4549_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1055\/s-0039-1697672","volume":"37","author":"RI Clyman","year":"2020","unstructured":"Clyman RI, Liebowitz M, Johng S et al (2020) Relationship between duration of infant exposure to a moderate-to-large patent ductus arteriosus shunt and the risk of developing bronchopulmonary dysplasia or death before 36 weeks. Am J Perinatol 37:216\u2013223. https:\/\/doi.org\/10.1055\/s-0039-1697672","journal-title":"Am J Perinatol"},{"key":"4549_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpeds.2021.04.014","volume":"235","author":"G Altit","year":"2021","unstructured":"Altit G, Saeed S, Beltempo M et al (2021) Outcomes of extremely premature infants comparing patent ductus arteriosus management approaches. J Pediatr 235:49\u201357.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2021.04.014","journal-title":"J Pediatr"},{"key":"4549_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpeds.2021.04.030","volume":"235","author":"D Relangi","year":"2021","unstructured":"Relangi D, Somashekar S, Jain D et al (2021) Changes in patent ductus arteriosus treatment strategy and respiratory outcomes in premature infants. J Pediatr 235:58\u201362. https:\/\/doi.org\/10.1016\/j.jpeds.2021.04.030","journal-title":"J Pediatr"},{"key":"4549_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2021.635616","volume":"9","author":"EK Choi","year":"2021","unstructured":"Choi EK, Park KH, Choi BM (2021) Size of patent ductus arteriosus and echocardiographic markers of shunt volume in preterm infants based on postnatal age. Front Pediatr 9:1\u20137. https:\/\/doi.org\/10.3389\/fped.2021.635616","journal-title":"Front Pediatr"},{"key":"4549_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.18904","volume":"4","author":"Y Cao","year":"2021","unstructured":"Cao Y, Jiang S, Sun J et al (2021) Assessment of neonatal intensive care unit practices, morbidity, and mortality among very preterm infants in China. JAMA Netw Open 4:1\u201313. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18904","journal-title":"JAMA Netw Open"},{"key":"4549_CR16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1080\/13696998.2020.1839272","volume":"23","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Wang J, Chen C, Zhou J (2020) Hospitalization charges for extremely preterm infants: a ten-year analysis in Shanghai, China. J Med Econ 23:1610\u20131617. https:\/\/doi.org\/10.1080\/13696998.2020.1839272","journal-title":"J Med Econ"},{"key":"4549_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-019-1736-8","volume":"19","author":"F Wu","year":"2019","unstructured":"Wu F, Liu G, Feng Z et al (2019) Short-term outcomes of extremely preterm infants at discharge: a multicenter study from Guangdong province during 2008\u20132017. BMC Pediatr 19:1\u201311. https:\/\/doi.org\/10.1186\/s12887-019-1736-8","journal-title":"BMC Pediatr"},{"key":"4549_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92:529\u2013534. https:\/\/doi.org\/10.1016\/S0022-3476(78)80282-0","journal-title":"J Pediatr"},{"key":"4549_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"M Bell","year":"1978","unstructured":"Bell M, Ternberg J, Feigin R et al (1978) Bell - Neonatal NEC - therapeutic decisions based upon clinical staging. Ann Surg 187:1\u20137","journal-title":"Ann Surg"},{"key":"4549_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/028418518702800404","volume":"28","author":"W Mortensson","year":"1987","unstructured":"Mortensson W, Noack G, Curstedt T et al (1987) Radiologic observations in severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant. Acta Radiol 28:389\u2013394","journal-title":"Acta Radiol"},{"key":"4549_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0031-3955(16)31876-4","volume":"13","author":"AJ Rudolph","year":"1966","unstructured":"Rudolph AJ, Desmond MM, Pineda RG (1966) Clinical diagnosis of respiratory difficulty in the newborn. Pediatr Clin North Am 13:669\u2013692. https:\/\/doi.org\/10.1016\/S0031-3955(16)31876-4","journal-title":"Pediatr Clin North Am"},{"key":"4549_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/fn.74.1.f26","volume":"74","author":"JR Skinner","year":"1996","unstructured":"Skinner JR, Hunter S, Hey EN (1996) Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome. Arch Dis Child 74:26\u201333. https:\/\/doi.org\/10.1136\/fn.74.1.f26","journal-title":"Arch Dis Child"},{"key":"4549_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","volume":"200","author":"K Dysart","year":"2019","unstructured":"Dysart K, Gantz MG, McDonald S et al (2019) The diagnosis of bronchopulmonary dysplasia in very preterm infants an evidence-based approach. Am J Respir Crit Care Med 200:751\u2013759. https:\/\/doi.org\/10.1164\/rccm.201812-2348OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4549_CR24","doi-asserted-by":"publisher","first-page":"F99","DOI":"10.1136\/archdischild-2013-304695","volume":"99","author":"M Kluckow","year":"2014","unstructured":"Kluckow M, Jeffery M, Gill A, Evans N (2014) A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 99:F99\u2013F104. https:\/\/doi.org\/10.1136\/archdischild-2013-304695","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"4549_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/0022-3468(93)90148-E","volume":"28","author":"T Trus","year":"1993","unstructured":"Trus T, Winthrop AL, Pipe S et al (1993) Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg 28:1137\u20131139. https:\/\/doi.org\/10.1016\/0022-3468(93)90148-E","journal-title":"J Pediatr Surg"},{"key":"4549_CR26","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0022-3476(09)90044-0","volume":"122","author":"MD Reller","year":"1993","unstructured":"Reller MD, Rice MJ, McDonald RW (1993) Review of studies evaluating ductal patency in the premature infant. J Pediatr 122:S59\u2013S62","journal-title":"J Pediatr"},{"key":"4549_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1203\/PDR.0b013e318163a8e4","volume":"63","author":"LY Chang","year":"2008","unstructured":"Chang LY, McCurnin D, Yoder B et al (2008) Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res 63:299\u2013302. https:\/\/doi.org\/10.1203\/PDR.0b013e318163a8e4","journal-title":"Pediatr Res"},{"key":"4549_CR28","doi-asserted-by":"publisher","unstructured":"Hamrick SEG, Sallmon H, Rose AT et al (2020) Patent ductus arteriosus of the preterm infant. Pediatrics 146. https:\/\/doi.org\/10.1542\/peds.2020-1209","DOI":"10.1542\/peds.2020-1209"},{"key":"4549_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/ajrccm.152.2.7633720","volume":"152","author":"JJ Coalson","year":"1995","unstructured":"Coalson JJ, Winter V (1995) Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 152:640\u2013646. https:\/\/doi.org\/10.1164\/ajrccm.152.2.7633720","journal-title":"Am J Respir Crit Care Med"},{"key":"4549_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/ajplung.00251.2009","volume":"298","author":"LM Mokres","year":"2010","unstructured":"Mokres LM, Parai K, Hilgendorff A et al (2010) Prolonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice. Am J Physiol - Lung Cell Mol Physiol 298:23\u201335. https:\/\/doi.org\/10.1152\/ajplung.00251.2009","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"4549_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1542\/peds.93.5.712","volume":"93","author":"P Groneck","year":"1994","unstructured":"Groneck P, G\u00f6tze-Speer B, Speer CP, Oppermann M, Eiffert H (1994) Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 93:712\u2013718","journal-title":"Pediatrics"},{"key":"4549_CR32","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jpeds.2015.03.012","volume":"166","author":"F Schena","year":"2015","unstructured":"Schena F, Francescato G, Cappelleri A et al (2015) Association between hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr 166:1488\u20131492. https:\/\/doi.org\/10.1016\/j.jpeds.2015.03.012","journal-title":"J Pediatr"},{"key":"4549_CR33","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41372-019-0496-5","volume":"39","author":"H Mirza","year":"2019","unstructured":"Mirza H, Garcia J, McKinley G et al (2019) Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants. J Perinatol 39:1648\u20131655. https:\/\/doi.org\/10.1038\/s41372-019-0496-5","journal-title":"J Perinatol"},{"key":"4549_CR34","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/s41372-020-0718-x","volume":"40","author":"RI Clyman","year":"2020","unstructured":"Clyman RI, Hills NK (2020) The effect of prolonged tracheal intubation on the association between patent ductus arteriosus and bronchopulmonary dysplasia (grades 2 and 3). J Perinatol 40:1358\u20131365. https:\/\/doi.org\/10.1038\/s41372-020-0718-x","journal-title":"J Perinatol"},{"key":"4549_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jpeds.2020.09.047","volume":"229","author":"RI Clyman","year":"2021","unstructured":"Clyman RI, Kaempf J, Liebowitz M et al (2021) Prolonged tracheal intubation and the association between patent ductus arteriosus and bronchopulmonary dysplasia: a secondary analysis of the PDA-TOLERATE trial. J Pediatr 229:283\u2013288.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.09.047","journal-title":"J Pediatr"},{"key":"4549_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0036-1593351","volume":"34","author":"A Lokku","year":"2017","unstructured":"Lokku A, Mirea L, Lee SK, Shah PS (2017) Trends and outcomes of patent ductus arteriosus treatment in very preterm infants in Canada. Am J Perinatol 34:441\u2013450. https:\/\/doi.org\/10.1055\/s-0036-1593351","journal-title":"Am J Perinatol"},{"key":"4549_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpeds.2017.05.024","volume":"189","author":"GM Bixler","year":"2017","unstructured":"Bixler GM, Powers GC, Clark RH et al (2017) Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units. J Pediatr 189:105\u2013112. https:\/\/doi.org\/10.1016\/j.jpeds.2017.05.024","journal-title":"J Pediatr"},{"key":"4549_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/adc.2007.118117","volume":"92","author":"PJ Mcnamara","year":"2007","unstructured":"Mcnamara PJ, Sehgal A (2007) Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal 92:424\u2013427. https:\/\/doi.org\/10.1136\/adc.2007.118117","journal-title":"Arch Dis Child Fetal Neonatal"},{"key":"4549_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clp.2020.05.007","volume":"47","author":"S Mitra","year":"2020","unstructured":"Mitra S, McNamara PJ (2020) Patent ductus arteriosus\u2014time for a definitive trial. Clin Perinatol 47:617\u2013639. https:\/\/doi.org\/10.1016\/j.clp.2020.05.007","journal-title":"Clin Perinatol"},{"key":"4549_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2020.11.008","volume":"52242","author":"DR Rios","year":"2020","unstructured":"Rios DR, de Freitas MF, El-Khuffash A et al (2020) Early role of the atrial level communication in premature infants with patent ductus arteriosus. J Am Soc Echocardiogr 52242:1\u201311. https:\/\/doi.org\/10.1016\/j.echo.2020.11.008","journal-title":"J Am Soc Echocardiogr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04549-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T10:11:39Z","timestamp":1659607899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04549-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4549"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04549-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted by the Research Ethics Board of Children\u2019s Hospital of Fudan University on December 8 2021 [REB# (2021) 475].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study was granted an exemption from requiring individual written informed consent due to its retrospective nature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}